CMS moves to cover drug prior auth
CMS proposed extending its electronic prior‑authorization interoperability framework to prescription drugs and shortening decision timelines, which would require new data exchange and public reporting for drug approvals and denials. The proposal was summarized by CMS and covered in a brief on April 12, 2026. (x.com) (satprwire.com)
The Centers for Medicare and Medicaid Services wants insurers in federal health programs to handle drug prior authorizations electronically and answer faster. (cms.gov) The proposal, released April 10, 2026, would set deadlines of no later than 24 hours for urgent drug requests and 72 hours for standard requests. It would also require public reporting of approval rates, denial rates, appeals outcomes, and decision times. (cms.gov) Prior authorization is the insurer’s preapproval check before a prescription is covered. CMS said its 2024 interoperability rule covered non-drug items and services, and this new proposal would extend many of those same digital requirements to drugs. (cms.gov) The rule would apply across Medicare Advantage, Medicaid, the Children’s Health Insurance Program, Qualified Health Plans sold on the federally facilitated exchanges, and small-group exchange plans on the federally facilitated Small Business Health Options Program. CMS said it is also proposing to add those small-group exchange issuers to the earlier interoperability framework. (cms.gov) Behind the policy is a technical shift away from fax, phone, and portal-by-portal paperwork. The Department of Health and Human Services said it would adopt Health Level Seven Fast Healthcare Interoperability Resources standards for prior-authorization transactions used by plans, providers, and clearinghouses that exchange these requests electronically. (cms.gov) The American Hospital Association said the proposal would have payers support application-programming-interface-driven prior authorization for drugs and would replace the current Health Insurance Portability and Accountability Act prior-authorization transaction, known as X12 278, with the newer application-programming-interface standards in these rules. (aha.org) For pharmacy-benefit drugs, Becker’s reported that Medicaid and Children’s Health Insurance Program fee-for-service plans, Medicaid and Children’s Health Insurance Program managed care plans, and exchange plans would have to support formulary lookups, real-time benefit checks, and electronic prior-authorization requests and responses beginning October 1, 2027. Becker’s also reported that the proposal would require specific denial reasons for some drug prior-authorization decisions. (beckershospitalreview.com) CMS framed the drug proposal as the next step after its earlier interoperability rules in 2020 and 2024. Those rules already required affected payers to build patient access, provider directory, provider access, payer-to-payer, and prior-authorization application programming interfaces for other parts of coverage. (cms.gov) The pressure for faster decisions has been building from both regulators and providers. The American Medical Association’s 2024 survey said prior authorization delays care, and AHIP said in June 2025 that health plans committed to answering at least 80 percent of electronic prior authorizations in real time by 2027 when complete documentation is submitted. (ama-assn.org) (ahip.org) This is still a proposed rule, not a final one. CMS said the goal is to move drug prior authorization into the same electronic, measurable system it already started building for medical services, with the next fight likely to center on how quickly plans and providers can actually wire those systems together. (cms.gov)
